Donaldson CEO Says Tariff Impact Is Immaterial, Raises Annual Profit Outlook
Written by Emily J. Thompson, Senior Investment Analyst
Source: Benzinga
Third-Quarter Financial Results: Donaldson Company reported a 1.3% increase in sales to $940.1 million but fell short of expectations, with net earnings dropping significantly due to non-recurring charges, including a major impairment of intangible assets.
Revised Guidance and Shareholder Returns: The company adjusted its FY25 guidance for adjusted EPS and sales growth, while also announcing an increase in cash dividends and plans for share repurchases, indicating confidence in achieving record sales and earnings for the year.
Analyst Views on DCI
Wall Street analysts forecast DCI stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for DCI is 102.25 USD with a low forecast of 93.00 USD and a high forecast of 120.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
5 Analyst Rating
2 Buy
3 Hold
0 Sell
Moderate Buy
Current: 102.370
Low
93.00
Averages
102.25
High
120.00
Current: 102.370
Low
93.00
Averages
102.25
High
120.00
About DCI
Donaldson Company, Inc. specializes in technology-led filtration products and solutions, serving a range of industries and advanced markets. The Company's segments include Mobile Solutions, Industrial Solutions and Life Sciences. Mobile Solutions segment is organized based on a combination of customers and products and consists of the off-road, on-road and aftermarket business units. Its products consist of replacement filters for both air and liquid filtration applications and filtration housings for new equipment production and systems related to exhaust and emissions. Industrial Solutions segment is organized based on product type and consists of industrial air filtration, industrial gases, industrial hydraulics, power generation and aerospace and defense products. Life Sciences segment is organized by end market and consists of the bioprocessing equipment and consumables, food and beverage, vehicle electrification and medical device, microelectronics and bioprocessing equipment.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
